acetylcysteine has been researched along with sodium bicarbonate in 89 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (6.74) | 18.7374 |
1990's | 3 (3.37) | 18.2507 |
2000's | 26 (29.21) | 29.6817 |
2010's | 49 (55.06) | 24.3611 |
2020's | 5 (5.62) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brasch, H; Pentz, R; Strubelt, O; Younes, M | 1 |
Donovan, J; Lippman, HR | 1 |
Chang, R; Marshall, FF; Singh, A | 1 |
Gittes, RF; Saltzman, N | 1 |
Burns, JR; Finlayson, B; Gauthier, JF | 1 |
Ackermann, D; Alken, P; Frohneberg, D; Weirich, W | 1 |
Dretler, SP; Pfister, RC | 1 |
Dunn, RJ | 1 |
Arima, S; Cho, JS; Majima, Y; Min, YG; Rhee, CS; Sakakura, Y | 1 |
MacNaughton, SM | 1 |
Burroughs, M; Grossman, PD; Guthmann, RA | 1 |
de Fijter, C; Schultz, MJ; Smit, W; Tonino, S; van den Berk, G | 1 |
Bridges, JM; Feldstein, DA | 1 |
Abitbol, C; Berho, ME; Chandar, J; Espinoza, V; Onder, AM; Zilleruelo, G | 1 |
Jia, H; Knowlton, G; Nykamp, D; Pang, D; Schmidt, P | 1 |
Airoldi, F; Bonizzoni, E; Briguori, C; Carlino, M; Colombo, A; Cosgrave, J; D'Andrea, D; Focaccio, A; Michev, I; Montorfano, M; Morici, N; Ricciardelli, B | 1 |
Banerjee, D; Chaparro, M; Cózar, R; Cruz, JM; Cubero, J; Kaski, JC; Méndez, I; Prado, B; Recio-Mayoral, A | 1 |
Mehran, R | 1 |
Akdeniz, B; Akyildiz, IZ; Aslan, O; Badak, O; Baris, N; Guneri, S; Ozcan, EE; Senaslan, O | 1 |
Enomoto, S; Hoshino, A; Kawahito, H; Kurata, H; Nakahara, Y; Nakamura, T | 1 |
Locatelli, F | 1 |
Bouzas-Mosquera, A; Vázquez-Rodríguez, JM | 1 |
Bouzas-Mosquera, A; Recio-Mayoral, A | 1 |
Bashir, I; DeLago, A; El-Hajjar, M; Khan, M; Min, J; Torosoff, M | 1 |
Massicotte, A | 1 |
Averbukh, Z; Berman, S; Efrati, S; Ilgiyeav, I; Siman-Tov, Y; Weissgarten, J | 1 |
Rudnick, MR; Sterling, KA; Tehrani, T | 1 |
Buckley, N; Dawson, AH; Fernandopulle, BM; Ranganathan, SS; Senarathna, SM | 1 |
Aublet-Cuvelier, B; Cellarier, E; Decalf, V; Deteix, P; Heng, AE; Marcaggi, X; Motreff, P; Souweine, B | 1 |
Hörl, WH | 1 |
Cronin, RE | 1 |
Coppola, JT; Doucet, S; Katholi, RE; Mody, KR; Sharma, SK; Solomon, R; Staniloae, CS | 1 |
Butnaru, A; Korenfeld, R; Lifschitz, M; Shavit, L; Slotki, I | 1 |
Cass, A; Gallagher, M; Huxley, R; Jardine, M; Ninomiya, T; Patel, A; Perkovic, V; Sadigh, G; Vasheghani-Farahani, A; Zoungas, S | 1 |
Block, CA; Brown, JR; Malenka, DJ; O'Connor, GT; Schoolwerth, AC; Thompson, CA | 1 |
Dauerman, HL | 1 |
Bosotti, L; Castini, D; Lombardi, F; Lucreziotti, S; Salerno Uriarte, D; Sponzilli, C; Verzoni, A | 1 |
Kagan, A; Sheikh-Hamad, D | 1 |
Caixeta, A; Mehran, R | 1 |
Brown, JR; Mautone, A | 1 |
Brown, JR; Thompson, CA | 1 |
Nadella, R; Szabo, A; Trivedi, H | 1 |
Marsh, A; Myall, K; Sidney, J | 1 |
Cheong, SS; Cho, YH; Choi, SW; Hyon, MS; Jang, JS; Kang, SJ; Kim, WJ; Kim, YH; Lee, BK; Lee, CW; Lee, JH; Lee, JY; Lee, NH; Lee, SG; Lee, SW; Park, DW; Park, SJ; Park, SW; Seong, IW; Shin, WY; Suh, J; Yoo, SY; Yun, SC | 1 |
Briguori, C; Condorelli, G; Ricciardelli, B; Visconti, G | 1 |
Allaqaband, S; Bajwa, T; Hafiz, AM; Jan, MF; Mori, N; Shaikh, F; Wallach, J | 1 |
Albarracín, LM; Bernasconi, AR; Heguilén, RM; Liste, AA; Ortemberg, MG; Payaslian, M | 1 |
Aurelio, A; Basile, E; Buffon, A; Burzotta, F; Crea, F; De Caterina, AR; Leone, AM; Lioy, E; Mazzari, MA; Mongiardo, R; Niccoli, G; Panocchia, N; Porto, I; Rebuzzi, AG; Romagnoli, E; Sciahbasi, A; Trani, C | 1 |
Kwok, CS; Loke, YK; Pang, CL; Yeong, JK | 1 |
Aloisi, C; Arena, A; Baldari, S; Buemi, F; Buemi, M; Giardina, C; Lacquaniti, A; Lupica, R; Murè, G; Visalli, C | 1 |
Alessandri, N; Di Matteo, A; Garante, CM; Lanzi, L; Petrassi, M; Sergiacomi, R; Tersigni, F; Tufano, F | 1 |
Brophy, MT; Cass, A; Chertow, GM; Conner, TA; Fine, MJ; Gallagher, M; Huang, GD; Kaufman, J; Lee, J; Lew, RA; McCullough, PA; Mor, MK; Palevsky, PM; Parikh, CR; Shunk, KA; Soliva, S; Weisbord, SD | 1 |
Jones, AE; Kellum, J; Mitchell, AM; Nelson, T; O'Connor, J; Shapiro, NI; Tang, A; Traub, SJ | 1 |
Christiansen, EH; Hansen, HS; Hansen, KN; Jensen, LO; Jensen, SE; Junker, A; Lassen, JF; Ravkilde, J; Thayssen, P; Thuesen, L; Veien, KT | 1 |
Li, J; Xu, G; Yan, W | 1 |
Liu, W; Lv, S; Ren, W; Yang, K | 1 |
Dervişoğlu, E; Doğan, NÖ; Erimşah, E; Kama, A; Pekdemir, M; Yaka, E; Yılmaz, S | 1 |
Caixeta, A; Inda-Filho, AJ; Manggini, M; Schor, N | 1 |
Akbari, H; Dorri, F; Hosseinzadeh, F; Iranirad, L; Miryounesi, M; Nazeri, A; Pazoki, S; Vafaeimanesh, J; Vahedian, M; Yeganehkhah, MR | 1 |
Chen, W; Liang, C; Liang, L; Zhang, B; Zhang, S | 1 |
Ali, RM; Azan, A; Chen, JY; Chen, SL; Chong, E; Fang, WY; Hou, XM; Lau, TW; Lu, Q; Ong, HY; Poh, KK; Tan, HC; Tan, N; Zhang, JJ | 1 |
Chong, E; Lu, Q; Poh, KK; Tan, HC | 1 |
Eyuboglu, M | 1 |
Askenazi, D; Cerda, J; de Caestecker, M; Faubel, S; Fissell, WH; Harrell, FE; Humphreys, BD; Liu, KD; Mour, G; Nolin, TD; Okusa, MD; Pullen, N | 1 |
Aboagye, J; Bass, EB; Choi, MJ; Eng, J; Hutfless, S; Sherrod, C; Suarez-Cuervo, C; Subramaniam, RM; Turban, S; Wilson, RF; Zhang, A | 1 |
Qi, GX; Tian, W; Zhao, SJ; Zhong, ZS | 1 |
Huang, T; Wang, L; Xu, G; Yan, W | 1 |
Icard, BL; Rubio, E | 1 |
Androsenko, M; Bhatt, DL; Brophy, M; Cass, A; Chertow, GM; Conner, TA; Ferguson, R; Gallagher, M; Garcia, S; Jneid, H; Kaufman, J; McFalls, EO; Myles, J; Palevsky, PM; Parikh, CR; Shunk, K; Thwin, SS; Weisbord, SD; Wu, H | 1 |
Huynh, K | 1 |
Solomon, R | 2 |
Han, XQ; Liu, NF; Ma, WQ; Wang, Y; Zhao, Y; Zhu, Y | 1 |
Carnicelli, AP; Granger, CB | 1 |
Gallagher, M; Palevsky, PM; Weisbord, SD | 1 |
Divyaveer, S; Makhija, R | 1 |
Čulić, V | 1 |
Kang, PS; Partovi, S; Trischman, T | 1 |
Müller, GA; Patschan, D | 1 |
Kaluski, E; Khan, MS; Khan, MU; Khan, SU; Novak, M; Opoku-Asare, I; Rahman, H; Riaz, H | 1 |
Fratita, M; Owens, R; O’Dwyer, M; Spring, A | 1 |
Kaufman, JS; Liu, C; Mor, MK; Palevsky, PM; Parikh, CR; Thiessen Philbrook, H; Weisbord, SD | 1 |
Kanlerd, A; Mahawongkajit, P | 1 |
Amin, A; Barón, AE; Gilmartin, HM; Keach, JW; Langner, P; Maddox, TM; Plomondon, ME; Stanislawski, MA; Waldo, S | 1 |
Gholamrezanezhad, A; Joyce, P; Salehi, S; Shin, H; Taghavifar, S | 1 |
Bell, S; Guthrie, GD; Lambourg, E; Plumb, A; Traill, P; Walker, H; Zealley, I | 1 |
30 review(s) available for acetylcysteine and sodium bicarbonate
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clinical inquiries. What interventions reduce the risk of contrast nephropathy for high-risk patients?
Topics: Acetylcysteine; Contrast Media; Hemofiltration; Humans; Kidney Diseases; Osmolar Concentration; Risk Factors; Sodium Bicarbonate; Sodium Chloride | 2005 |
Bench-to-bedside review: preventive measures for contrast-induced nephropathy in critically ill patients.
Topics: Acetylcysteine; Contrast Media; Critical Care; Fenoldopam; Free Radical Scavengers; Hemofiltration; Humans; Kidney Diseases; Sodium Bicarbonate; Theophylline; Treatment Outcome; Vasodilator Agents | 2005 |
Acute renal failure due to phenazopyridine (Pyridium) overdose: case report and review of the literature.
Topics: Acetylcysteine; Acute Kidney Injury; Adolescent; Carnitine; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Methemoglobinemia; Phenazopyridine; Sodium Bicarbonate; Suicide, Attempted; Treatment Outcome | 2006 |
Contrast-induced nephropathy remains a serious complication of PCI.
Topics: Acetylcysteine; Angioplasty, Balloon, Coronary; Contrast Media; Disease Progression; Fenoldopam; Humans; Incidence; Kidney Diseases; Prognosis; Risk Factors; Sodium Bicarbonate | 2007 |
Contrast medium-induced nephropathy: strategies for prevention.
Topics: Acetylcysteine; Administration, Oral; Contrast Media; Dose-Response Relationship, Drug; Humans; Injections, Intravenous; Kidney Diseases; Pharmacists; Risk Factors; Sodium Bicarbonate | 2008 |
Clinical significance and preventive strategies for contrast-induced nephropathy.
Topics: Acetylcysteine; Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Ascorbic Acid; Contrast Media; Fluid Therapy; Hemofiltration; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; Renal Dialysis; Sodium Bicarbonate; Theophylline | 2008 |
[Contrast induced nephropathy].
Topics: Acetylcysteine; Acute Kidney Injury; Algorithms; Contrast Media; Creatinine; Critical Care; Fluid Therapy; Glomerular Filtration Rate; Hospital Mortality; Humans; Kidney Failure, Chronic; Osmolar Concentration; Renal Dialysis; Risk Factors; Sodium Bicarbonate; Theophylline | 2009 |
Contrast-induced nephropathy: pathogenesis and prevention.
Topics: Acetylcysteine; Contrast Media; Health Planning Guidelines; Humans; Isotonic Solutions; Kidney Diseases; Randomized Controlled Trials as Topic; Risk Factors; Sodium Bicarbonate; Sodium Chloride | 2010 |
Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy.
Topics: Acetylcysteine; Contrast Media; Heart Failure; Humans; Injections, Intravenous; Kidney Diseases; Mortality; Renal Dialysis; Risk; Sodium Bicarbonate | 2009 |
Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Oral; Biomarkers; Contrast Media; Creatinine; Drug Therapy, Combination; Evidence-Based Medicine; Free Radical Scavengers; Humans; Infusions, Intravenous; Kidney Diseases; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Assessment; Sodium Bicarbonate; Treatment Outcome | 2009 |
Contrast-induced kidney injury: focus on modifiable risk factors and prophylactic strategies.
Topics: Acetylcysteine; Acute Disease; Animals; Combined Modality Therapy; Contrast Media; Cytoprotection; Evidence-Based Medicine; Fluid Therapy; Hemofiltration; Humans; Kidney Diseases; Practice Guidelines as Topic; Renal Dialysis; Risk Assessment; Risk Factors; Sodium Bicarbonate; Treatment Outcome | 2010 |
Evidence-based management of patients undergoing PCI: contrast-induced acute kidney injury.
Topics: Acetylcysteine; Acute Disease; Angioplasty, Balloon, Coronary; Contrast Media; Dopamine; Drug Administration Routes; Evidence-Based Medicine; Fenoldopam; Fluid Therapy; Humans; Kidney Diseases; Patient Selection; Practice Guidelines as Topic; Protective Agents; Radiography, Interventional; Risk Assessment; Risk Factors; Sodium Bicarbonate; Treatment Outcome | 2010 |
Contrast-induced nephropathy in patients undergoing elective and urgent procedures.
Topics: Acetylcysteine; Acute Disease; Acute Kidney Injury; Adenosine; Ascorbic Acid; Contrast Media; Elective Surgical Procedures; Emergency Treatment; Free Radical Scavengers; General Surgery; Glomerular Filtration Rate; Humans; Hydrotherapy; Preoperative Care; Renal Dialysis; Risk Assessment; Sodium Bicarbonate | 2010 |
Contrast-induced acute kidney injury: the at-risk patient and protective measures.
Topics: Acetylcysteine; Acute Kidney Injury; Biomarkers; Cardiac Catheterization; Contrast Media; Drug Therapy, Combination; Free Radical Scavengers; Humans; Hydrotherapy; Risk Assessment; Risk Factors; Sodium Bicarbonate | 2010 |
Hydration with sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of randomized controlled trials.
Topics: Acetylcysteine; Contrast Media; Humans; Kidney Diseases; Randomized Controlled Trials as Topic; Sodium Bicarbonate; Sodium Chloride | 2010 |
Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Topics: Acetylcysteine; Acute Kidney Injury; Biomarkers; Chi-Square Distribution; Chronic Disease; Contrast Media; Creatinine; Diuretics; Drug Therapy, Combination; Equipment Design; Fluid Therapy; Furosemide; Glomerular Filtration Rate; Humans; Italy; Kidney Diseases; Radiography, Interventional; Renal Insufficiency; Research Design; Risk Assessment; Risk Factors; Sodium Bicarbonate; Time Factors; Treatment Outcome; Triiodobenzoic Acids | 2011 |
Measures used to treat contrast-induced nephropathy: overview of reviews.
Topics: Acetylcysteine; Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; Prevalence; Risk Assessment; Sodium Bicarbonate; Theophylline; Treatment Outcome | 2013 |
Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Intravenous; Angiography; Contrast Media; Free Radical Scavengers; Humans; Randomized Controlled Trials as Topic; Research Design; Sodium Bicarbonate | 2013 |
An update for the controversies and hypotheses of regulating nonthyroidal illness syndrome in chronic kidney diseases.
Topics: Acetylcysteine; Comorbidity; Cytokines; Disease Progression; Euthyroid Sick Syndromes; Hormone Replacement Therapy; Humans; Oxidative Stress; Renal Insufficiency, Chronic; Sodium Bicarbonate; Thyroid Hormones | 2014 |
The efficacy of sodium bicarbonate in preventing contrast-induced nephropathy in patients with pre-existing renal insufficiency: a meta-analysis.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Fluid Therapy; Free Radical Scavengers; Humans; Osmolar Concentration; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency; Sodium Bicarbonate | 2015 |
Bridging Translation by Improving Preclinical Study Design in AKI.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Contrast Media; Disease Models, Animal; Erythropoietin; Free Radical Scavengers; Humans; Research Design; Sodium Bicarbonate; Translational Research, Biomedical | 2015 |
Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis.
Topics: Acetylcysteine; Antioxidants; Ascorbic Acid; Contrast Media; Free Radical Scavengers; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infusions, Intra-Arterial; Infusions, Intravenous; Kidney Diseases; Odds Ratio; Sodium Bicarbonate; Sodium Chloride; United States | 2016 |
The efficacy of N-acetylcysteine plus sodium bicarbonate in the prevention of contrast-induced nephropathy after cardiac catheterization and percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
Topics: Acetylcysteine; Acute Kidney Injury; Cardiac Catheterization; Contrast Media; Drug Therapy, Combination; Humans; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Sodium Bicarbonate; Treatment Outcome | 2016 |
The role of mucoactive agents in the mechanically ventilated patient: a review of the literature.
Topics: Acetylcysteine; Ambroxol; Critical Care; Critical Illness; Deoxyribonuclease I; Expectorants; Guaifenesin; Humans; Intensive Care Units; Mannitol; Mucociliary Clearance; Potassium Dichromate; Recombinant Proteins; Respiration, Artificial; Saline Solution, Hypertonic; Sodium Bicarbonate | 2017 |
Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Coronary Angiography; Drug Therapy, Combination; Free Radical Scavengers; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Natriuretic Peptide, Brain; Network Meta-Analysis; Prostaglandins; Randomized Controlled Trials as Topic; Sodium Bicarbonate; Vitamins | 2018 |
[Acute Kidney Injury, AKI - Update 2018].
Topics: Acetylcysteine; Acute Kidney Injury; Atherosclerosis; Clinical Trials as Topic; Contrast Media; Hematopoietic Stem Cell Transplantation; Humans; Multicenter Studies as Topic; Sodium Bicarbonate; Sodium Chloride; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2018 |
A Bayesian network meta-analysis of preventive strategies for contrast-induced nephropathy after cardiac catheterization.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Bayes Theorem; Cardiac Catheterization; Contrast Media; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Network Meta-Analysis; Protective Factors; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Assessment; Risk Factors; Sodium Bicarbonate | 2019 |
Current comments on contrast media administration in patients with renal insufficiency.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Humans; Kidney Diseases; Renal Insufficiency; Sodium Bicarbonate | 2021 |
Systematic review and meta-analysis of prophylaxis use with intravenous contrast exposure to prevent contrast-induced nephropathy.
Topics: Acetylcysteine; Adult; Contrast Media; Humans; Kidney Diseases; Renal Insufficiency; Sodium Bicarbonate | 2022 |
22 trial(s) available for acetylcysteine and sodium bicarbonate
Article | Year |
---|---|
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; Creatinine; Double-Blind Method; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Infusions, Intravenous; Kidney Diseases; Male; Renal Insufficiency; Risk Factors; Sodium Bicarbonate; Sodium Chloride; Treatment Outcome; Triiodobenzoic Acids | 2007 |
The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study.
Topics: Acetylcysteine; Aged; Angioplasty, Balloon, Coronary; Coronary Disease; Emergency Medical Services; Female; Fluid Therapy; Humans; Male; Middle Aged; Prospective Studies; Single-Blind Method; Sodium Bicarbonate | 2007 |
Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Female; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Sodium Bicarbonate; Sodium Chloride | 2007 |
Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date?
Topics: Acetylcysteine; Aged; Contrast Media; Coronary Angiography; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Injections, Intravenous; Iopamidol; Kidney Diseases; Male; Prospective Studies; Sodium Bicarbonate; Treatment Outcome; Triiodobenzoic Acids | 2008 |
Sodium bicarbonate versus sodium chloride and oral N-acetylcysteine for the prevention of contrast-induced nephropathy in advanced chronic kidney disease.
Topics: Acetylcysteine; Aged; Cardiac Catheterization; Contrast Media; Creatine; Dehydration; Female; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Prospective Studies; Regression Analysis; Risk Assessment; Sodium Bicarbonate; Sodium Chloride; Statistics as Topic | 2009 |
Prevention of contrast-induced nephropathy: a single center randomized study.
Topics: Acetylcysteine; Acute Disease; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Female; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Incidence; Kidney Diseases; Male; Prospective Studies; Sodium Bicarbonate; Sodium Chloride | 2010 |
Preventive strategies of renal insufficiency in patients with diabetes undergoing intervention or arteriography (the PREVENT Trial).
Topics: Acetylcysteine; Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Creatinine; Diabetic Nephropathies; Female; Humans; Male; Middle Aged; Renal Insufficiency; Sodium Bicarbonate; Sodium Chloride | 2011 |
Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Topics: Acetylcysteine; Acute Kidney Injury; Biomarkers; Chi-Square Distribution; Chronic Disease; Contrast Media; Creatinine; Diuretics; Drug Therapy, Combination; Equipment Design; Fluid Therapy; Furosemide; Glomerular Filtration Rate; Humans; Italy; Kidney Diseases; Radiography, Interventional; Renal Insufficiency; Research Design; Risk Assessment; Risk Factors; Sodium Bicarbonate; Time Factors; Treatment Outcome; Triiodobenzoic Acids | 2011 |
Prevention of contrast-induced acute kidney injury in patients with stable chronic renal disease undergoing elective percutaneous coronary and peripheral interventions: randomized comparison of two preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Aged, 80 and over; Biomarkers; Cardiac Catheterization; Catheterization, Peripheral; Chi-Square Distribution; Contrast Media; Coronary Angiography; Creatinine; Female; Fluid Therapy; Humans; Infusions, Intravenous; Kidney Diseases; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Renal Insufficiency; Risk Assessment; Risk Factors; Sodium Bicarbonate; Sodium Chloride; Time Factors; Treatment Outcome; Vascular Diseases; Wisconsin | 2012 |
N-acethyl-cysteine reduces the occurrence of contrast-induced acute kidney injury in patients with renal dysfunction: a single-center randomized controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Aged; Contrast Media; Creatinine; Female; Humans; Male; Middle Aged; Plasma Substitutes; Renal Insufficiency; Sodium Bicarbonate; Sodium Chloride; Triiodobenzoic Acids | 2013 |
Can neutrophil gelatinase-associated lipocalin help depict early contrast material-induced nephropathy?
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Contrast Media; Creatinine; Diagnostic Imaging; Enzyme-Linked Immunosorbent Assay; Female; Gelatinases; Glomerular Filtration Rate; Humans; Iopamidol; Kidney Diseases; Lipocalins; Male; Meglumine; Middle Aged; Organometallic Compounds; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Risk Factors; ROC Curve; Sensitivity and Specificity; Sodium Bicarbonate; Sodium Chloride | 2013 |
N-acetylcysteine plus intravenous fluids versus intravenous fluids alone to prevent contrast-induced nephropathy in emergency computed tomography.
Topics: Acetylcysteine; Adult; Contrast Media; Crystalloid Solutions; Double-Blind Method; Female; Humans; Infusions, Intravenous; Isotonic Solutions; Kidney Diseases; Male; Sodium Bicarbonate; Sodium Chloride; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial.
Topics: Acetylcysteine; Aged; Contrast Media; Creatinine; Drug Therapy, Combination; Electrocardiography; Female; Humans; Incidence; Infusions, Intravenous; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Prospective Studies; Sodium Bicarbonate; Treatment Outcome | 2014 |
Different interventions in preventing contrast-induced nephropathy after percutaneous coronary intervention.
Topics: Acetylcysteine; Administration, Oral; Contrast Media; Female; Humans; Kidney Diseases; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; Single-Blind Method; Sodium Bicarbonate; Sodium Chloride | 2014 |
Comparison of short-term infusion regimens of N-acetylcysteine plus intravenous fluids, sodium bicarbonate plus intravenous fluids, and intravenous fluids alone for prevention of contrast-induced nephropathy in the emergency department.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Drug Administration Schedule; Drug Therapy, Combination; Emergency Service, Hospital; Female; Humans; Infusions, Intravenous; Iohexol; Kidney Diseases; Male; Middle Aged; Prospective Studies; Protective Agents; Sodium Bicarbonate; Sodium Chloride; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2014 |
Do intravenous N-acetylcysteine and sodium bicarbonate prevent high osmolal contrast-induced acute kidney injury? A randomized controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Intravenous; Contrast Media; Coronary Angiography; Female; Humans; Iothalamic Acid; Male; Middle Aged; Osmolar Concentration; Sodium Bicarbonate | 2014 |
Comparison between three supportive treatments for prevention of contrast-induced nephropathy in high-risk patients undergoing coronary angiography.
Topics: Acetylcysteine; Aged; Antioxidants; Biomarkers; Blood Urea Nitrogen; Contrast Media; Coronary Angiography; Creatinine; Female; Fluid Therapy; Humans; Hydrogen-Ion Concentration; Iohexol; Iran; Kidney Diseases; Male; Middle Aged; Risk Factors; Sodium Bicarbonate; Sodium Chloride; Time Factors; Treatment Outcome | 2014 |
Comparison of combination therapy of high-dose oral N-acetylcysteine and intravenous sodium bicarbonate hydration with individual therapies in the reduction of Contrast-induced Nephropathy during Cardiac Catheterisation and Percutaneous Coronary Intervent
Topics: Acetylcysteine; Administration, Oral; Aged; Cardiac Catheterization; China; Contrast Media; Coronary Angiography; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluid Therapy; Follow-Up Studies; Glomerular Filtration Rate; Humans; Incidence; Infusions, Intravenous; Kidney Function Tests; Malaysia; Male; Percutaneous Coronary Intervention; Prognosis; Renal Insufficiency; Singapore; Sodium Bicarbonate; Survival Rate | 2015 |
Treatment for non-thyroidal illness syndrome in advanced chronic kidney disease: a single-blind controlled study.
Topics: Acetylcysteine; Chi-Square Distribution; China; Disease Progression; Euthyroid Sick Syndromes; Female; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Proportional Hazards Models; Renal Insufficiency, Chronic; Risk Factors; Single-Blind Method; Sodium Bicarbonate; Time Factors; Treatment Outcome | 2017 |
Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Oral; Aged; Angiography; Contrast Media; Creatinine; Double-Blind Method; Female; Fluid Therapy; Humans; Infusions, Intravenous; Male; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Sodium Bicarbonate; Sodium Chloride; Treatment Outcome | 2018 |
Kidney Biomarkers of Injury and Repair as Predictors of Contrast-Associated AKI: A Substudy of the PRESERVE Trial.
Topics: Acetylcysteine; Acute Kidney Injury; Acute-Phase Proteins; Administration, Oral; Aged; Angiography; Biomarkers; Contrast Media; Cytokines; Female; Follow-Up Studies; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Infusions, Intravenous; Kidney Function Tests; Male; Prognosis; Sodium Bicarbonate | 2020 |
A prospective randomized controlled trial comparing simethicone, N-acetylcysteine, sodium bicarbonate and peppermint for visualization in upper gastrointestinal endoscopy.
Topics: Acetylcysteine; Endoscopy, Gastrointestinal; Female; Humans; Male; Mentha piperita; Middle Aged; Prospective Studies; Quality of Life; Simethicone; Sodium Bicarbonate | 2021 |
38 other study(ies) available for acetylcysteine and sodium bicarbonate
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Experimental studies on the acute cardiovascular toxicity of formalin and its antidotal treatment.
Topics: Acetylcysteine; Animals; Antidotes; Bicarbonates; Cysteine; Formaldehyde; Heart Rate; Hemodynamics; Infusions, Intravenous; Male; Rats; Rats, Inbred Strains; Sodium; Sodium Bicarbonate | 1990 |
Re: Percutaneous catheter dissolution of cystine calculi.
Topics: Acetylcysteine; Bicarbonates; Cystine; Humans; Hydrogen-Ion Concentration; Kidney Calculi; Male; Middle Aged; Nephrostomy, Percutaneous; Sodium; Sodium Bicarbonate; Therapeutic Irrigation | 1988 |
Cystine calculi: clinical management and in vitro observations.
Topics: Acetylcysteine; Adult; Ascorbic Acid; Bicarbonates; Cystine; Cystinuria; Female; Homozygote; Humans; Kidney Calculi; Male; Middle Aged; Penicillamine; Sodium; Sodium Bicarbonate; Tromethamine | 1988 |
Chemolysis of cystine calculi.
Topics: Acetylcysteine; Bicarbonates; Cystine; Drug Synergism; Humans; Sodium; Sodium Bicarbonate; Sodium Hydroxide; Tromethamine; Urinary Calculi | 1986 |
Dissolution kinetics of uric acid calculi.
Topics: Acetylcysteine; Bicarbonates; Electrolytes; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Kinetics; Sodium Bicarbonate; Sodium Chloride; Solubility; Tromethamine; Uric Acid; Urinary Calculi | 1984 |
[Practical experiences with antegrade local chemolysis of struvite/apatite, uric acid and cystine calculi in the kidney].
Topics: Acetylcysteine; Apatites; Bicarbonates; Citrates; Combined Modality Therapy; Cystine; Female; Humans; Kidney Calculi; Magnesium; Magnesium Compounds; Male; Middle Aged; Phosphates; Recurrence; Sodium Bicarbonate; Struvite; Therapeutic Irrigation; Uric Acid | 1984 |
Percutaneous chemolysis of renal calculi.
Topics: Acetylcysteine; Bicarbonates; Citrates; Female; Humans; Hydrogen-Ion Concentration; Kidney Calculi; Male; Punctures; Radiography; Recurrence; Sodium Bicarbonate; Solvents; Therapeutic Irrigation; Tromethamine; Urinary Catheterization | 1984 |
Massive sulfasalazine and paracetamol ingestion causing acidosis, hyperglycemia, coagulopathy, and methemoglobinemia.
Topics: Acetaminophen; Acetylcysteine; Acidosis, Lactic; Acute Disease; Adult; Anti-Inflammatory Agents; Blood Coagulation Disorders; Blood Platelets; Drug Combinations; Drug Overdose; Humans; Hyperglycemia; Infusions, Intravenous; Male; Methemoglobinemia; Methylene Blue; Partial Thromboplastin Time; Sodium Bicarbonate; Suicide, Attempted; Sulfasalazine | 1998 |
Effects of mucokinetic drugs on rheological properties of reconstituted human nasal mucus.
Topics: Acetylcysteine; Adolescent; Adult; Child; Deoxyribonucleases; Expectorants; Female; Humans; Male; Middle Aged; Mucus; Nasal Mucosa; Polyethylene Glycols; Rheology; Sinusitis; Sodium Bicarbonate; Viscosity | 1999 |
Acetaminophen toxicosis in a Dalmatian.
Topics: Acetaminophen; Acetylcysteine; Analgesics, Non-Narcotic; Animals; Ascorbic Acid; Dog Diseases; Dogs; Emergency Treatment; Female; Fluid Therapy; Free Radical Scavengers; Liver; Methemoglobinemia; Sodium Bicarbonate; Treatment Outcome | 2003 |
Preventing contrast-induced nephropathy: a basic solution.
Topics: Acetylcysteine; Contrast Media; Diabetes Complications; Humans; Male; Middle Aged; Renal Insufficiency; Sodium Bicarbonate; Sodium Chloride | 2005 |
N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography.
Topics: Acetylcysteine; Aged; Contrast Media; Coronary Angiography; Drug Therapy, Combination; Female; Fluid Therapy; Humans; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Sodium Bicarbonate | 2007 |
[Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents].
Topics: Acetylcysteine; Administration, Oral; Aged; Cardiac Catheterization; Contrast Media; Coronary Angiography; Critical Pathways; Female; Humans; Kidney Diseases; Male; Middle Aged; Osmolar Concentration; Renal Insufficiency, Chronic; Sodium Bicarbonate | 2007 |
Letter regarding article by Solomon et al, "Cardiac Angiography in REnally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease".
Topics: Acetylcysteine; Confounding Factors, Epidemiologic; Contrast Media; Coronary Angiography; Creatinine; Double-Blind Method; Humans; Iopamidol; Kidney Diseases; Randomized Controlled Trials as Topic; Research Design; Sampling Studies; Sodium Bicarbonate; Triiodobenzoic Acids | 2008 |
Prevention of contrast-induced nephropathy in patients undergoing emergent coronary procedures.
Topics: Acetylcysteine; Contrast Media; Coronary Disease; Diagnostic Techniques, Cardiovascular; Free Radical Scavengers; Humans; Prognosis; Renal Insufficiency; Risk Factors; Sodium Bicarbonate | 2008 |
Sodium bicarbonate, N-acetylcysteine, and saline for the prevention of contrast-induced nephropathy.
Topics: Acetylcysteine; Angioplasty, Balloon, Coronary; Contrast Media; Drug Therapy, Combination; Humans; Kidney Diseases; Sodium Bicarbonate; Sodium Chloride | 2008 |
Incidence of contrast-induced nephropathy in patients with chronic renal insufficiency undergoing multidetector computed tomographic angiography treated with preventive measures.
Topics: Acetylcysteine; Aged; Angiography; Contrast Media; Coronary Angiography; Creatinine; Female; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Sodium Bicarbonate; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2008 |
Differential effects of N-acetylcysteine, theophylline or bicarbonate on contrast-induced rat renal vasoconstriction.
Topics: Acetylcysteine; Animals; Contrast Media; Dinoprostone; Free Radical Scavengers; Hypoxia; Iothalamic Acid; Isoprostanes; Kidney; Microcirculation; Nitric Oxide; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Sodium Bicarbonate; Theophylline; Vasoconstriction; Vasodilator Agents | 2009 |
Management of acute paracetamol poisoning in a tertiary care hospital.
Topics: Acetaminophen; Acetylcysteine; Acute Disease; Analgesics, Non-Narcotic; Antidotes; Charcoal; Emetics; Evidence-Based Medicine; Female; Hospitals, Public; Humans; Male; Methionine; Poisoning; Sodium Bicarbonate; Sri Lanka; Time Factors; Treatment Outcome; Young Adult | 2008 |
N-Acetylcysteine added to volume expansion with sodium bicarbonate does not further prevent contrast-induced nephropathy: results from the cardiac angiography in renally impaired patients study.
Topics: Acetylcysteine; Aged; Buffers; Coronary Angiography; Creatinine; Female; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Iopamidol; Kidney Diseases; Male; Plasma Substitutes; Retrospective Studies; Risk Factors; Sodium Bicarbonate; Triiodobenzoic Acids | 2009 |
In search of an algorithm to prevent acute kidney injury.
Topics: Acetylcysteine; Acute Kidney Injury; Algorithms; Clinical Protocols; Contrast Media; Drug Therapy, Combination; Evidence-Based Medicine; Free Radical Scavengers; Humans; Kidney Diseases; Practice Guidelines as Topic; Risk Assessment; Sodium Bicarbonate; Treatment Outcome | 2009 |
Mind the gap! An unusual metabolic acidosis.
Topics: Acetaminophen; Acetylcysteine; Acidosis; Anti-Bacterial Agents; Antioxidants; Female; Floxacillin; Humans; Middle Aged; Pyrrolidonecarboxylic Acid; Sepsis; Sodium Bicarbonate | 2011 |
Sodium bicarbonate plus N-acetylcysteine to prevent contrast-induced nephropathy in primary and rescue percutaneous coronary interventions: the BINARIO (BIcarbonato e N-Acetil-cisteina nell'infaRto mIocardico acutO) study.
Topics: Acetylcysteine; Aged; Contrast Media; Female; Fluid Therapy; Hospital Mortality; Humans; Italy; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Prospective Studies; Registries; Renal Dialysis; Retrospective Studies; Risk Factors; Sodium Bicarbonate; Time Factors; Treatment Outcome | 2012 |
Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Biomarkers; Cardiology; Contrast Media; Coronary Angiography; Creatinine; Female; Fluid Therapy; Glomerular Filtration Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Randomized Controlled Trials as Topic; Retrospective Studies; Sodium Bicarbonate; Sodium Chloride; Time Factors; Treatment Outcome | 2013 |
Reply to "Renin-angiotensin-aldosterone-system blockade and contrast-induced nephropathy".
Topics: Acetylcysteine; Cardiac Catheterization; Contrast Media; Female; Fluid Therapy; Humans; Male; Percutaneous Coronary Intervention; Renal Insufficiency; Sodium Bicarbonate | 2016 |
Renin-angiotensin-aldosterone-system blockade and contrast-induced nephropathy.
Topics: Acetylcysteine; Cardiac Catheterization; Contrast Media; Female; Fluid Therapy; Humans; Male; Percutaneous Coronary Intervention; Renal Insufficiency; Sodium Bicarbonate | 2016 |
Acute kidney injury: Preventing angiography-associated kidney injury.
Topics: Acetylcysteine; Acute Kidney Injury; Angiography; Humans; Kidney; Sodium Bicarbonate | 2018 |
Acute kidney injury: Antioxidants do not PRESERVE kidney function after contrast exposure.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Oral; Aged; Angiography; Contrast Media; Creatinine; Double-Blind Method; Female; Fluid Therapy; Humans; Infusions, Intravenous; Male; Middle Aged; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Sodium Bicarbonate; Sodium Chloride; Treatment Outcome | 2018 |
Sodium bicarb vs sodium chloride, and acetylcysteine vs placebo, did not differ for adverse events after angiography.
Topics: Acetylcysteine; Angiography; Contrast Media; Sodium; Sodium Bicarbonate; Sodium Chloride | 2018 |
Angiography with Sodium Bicarbonate and Acetylcysteine.
Topics: Acetylcysteine; Angiography; Contrast Media; Coronary Angiography; Humans; Kidney Diseases; Sodium Bicarbonate; Sodium Chloride | 2018 |
Angiography with Sodium Bicarbonate and Acetylcysteine.
Topics: Acetylcysteine; Angiography; Contrast Media; Humans; Sodium Bicarbonate | 2018 |
Angiography with Sodium Bicarbonate and Acetylcysteine.
Topics: Acetylcysteine; Angiography; Contrast Media; Humans; Sodium Bicarbonate | 2018 |
PRESERVE: The End or the Beginning of a New Era in Prevention of Contrast-Associated Acute Kidney Injury?
Topics: Acetylcysteine; Acute Kidney Injury; Angiography; Humans; Sodium Bicarbonate | 2018 |
Lessons learned from the PRESERVE trial.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Intravenous; Administration, Oral; Angiography; Contrast Media; Female; Free Radical Scavengers; Humans; Male; Randomized Controlled Trials as Topic; Reactive Oxygen Species; Research Design; Sodium Bicarbonate | 2018 |
An Under-Recognised Cause of Iatrogenic, Severe Metabolic Acidosis
Topics: Acetaminophen; Acetylcysteine; Acidosis; Aged, 80 and over; Anti-Bacterial Agents; Antipyretics; Arthroplasty, Replacement, Hip; Blood Gas Analysis; Drug Interactions; Floxacillin; Hip Prosthesis; Humans; Iatrogenic Disease; Male; Prosthesis-Related Infections; Pyrrolidonecarboxylic Acid; Renal Insufficiency, Chronic; Renal Replacement Therapy; Severity of Illness Index; Sodium Bicarbonate; Staphylococcal Infections; Surgical Wound Infection | 2019 |
Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Female; Fluid Therapy; Free Radical Scavengers; Glomerular Filtration Rate; Heart Failure; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Perioperative Care; Postoperative Complications; Practice Guidelines as Topic; Renal Insufficiency, Chronic; Saline Solution; Sodium Bicarbonate; United States; Veterans Health Services | 2020 |